Search research articles
Contact Us
Filters
Showing results (91-100 of 349) with videos related to
Page
of 35
Sort By:
Journal of the American College of Cardiology
|
January 21, 2017
Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies
Markus C Elze, John Gregson, Usman Baber, et al.
European Journal of Heart Failure
|
March 5, 2024
Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis
João Pedro Ferreira, Faiez Zannad, Milton Packer, et al.
Cardiovascular Diabetology
|
April 26, 2008
Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study)
Michel Komajda, Paula Curtis, Markolf Hanefeld, et al.
Diabetes Research and Clinical Practice
|
May 22, 2024
Impact of empagliflozin on first and recurrent events leading to or prolonging hospitalisation in the EMPA-REG OUTCOME trial
Silvio E Inzucchi, Christoph Wanner, David Fitchett, et al.
Journal of the American College of Cardiology
|
June 11, 2021
Implications of Biomarker Discordance After Coronary Artery Revascularization: The EXCEL Trial
Björn Redfors, John Gregson, Ori Ben-Yehuda, et al.
Journal of the American College of Cardiology
|
February 15, 2015
Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials
Gennaro Giustino, Usman Baber, Samantha Sartori, et al.
JACC. Heart Failure
|
November 3, 2022
Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTs
João Pedro Ferreira, Bertram Pitt, John J V McMurray, et al.
Annals of Internal Medicine
|
October 4, 2017
Predicting 30-Day Mortality for Patients With Acute Heart Failure in the Emergency Department: A Cohort Study
Òscar Miró, Xavier Rossello, Víctor Gil, et al.
The New England Journal of Medicine
|
June 7, 2007
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis
Philip D Home, Stuart J Pocock, Henning Beck-Nielsen, et al.
Journal of Cardiac Failure
|
April 21, 2025
NSAIDs Use, Kidney Outcomes and the Effect of Empagliflozin: An Analysis from EMPEROR-Preserved
João Pedro Ferreira, Faiez Zannad, Francisco Vasques-Nóvoa, et al.
Page
of 35
Search research articles
Search
Showing results (91-100 of 349) with videos related to
Sort By:
Page
of 35
Journal of the American College of Cardiology
|
January 21, 2017
Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies
Markus C Elze, John Gregson, Usman Baber, et al.
European Journal of Heart Failure
|
March 5, 2024
Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis
João Pedro Ferreira, Faiez Zannad, Milton Packer, et al.
Cardiovascular Diabetology
|
April 26, 2008
Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study)
Michel Komajda, Paula Curtis, Markolf Hanefeld, et al.
Diabetes Research and Clinical Practice
|
May 22, 2024
Impact of empagliflozin on first and recurrent events leading to or prolonging hospitalisation in the EMPA-REG OUTCOME trial
Silvio E Inzucchi, Christoph Wanner, David Fitchett, et al.
Journal of the American College of Cardiology
|
June 11, 2021
Implications of Biomarker Discordance After Coronary Artery Revascularization: The EXCEL Trial
Björn Redfors, John Gregson, Ori Ben-Yehuda, et al.
Journal of the American College of Cardiology
|
February 15, 2015
Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials
Gennaro Giustino, Usman Baber, Samantha Sartori, et al.
JACC. Heart Failure
|
November 3, 2022
Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTs
João Pedro Ferreira, Bertram Pitt, John J V McMurray, et al.
Annals of Internal Medicine
|
October 4, 2017
Predicting 30-Day Mortality for Patients With Acute Heart Failure in the Emergency Department: A Cohort Study
Òscar Miró, Xavier Rossello, Víctor Gil, et al.
The New England Journal of Medicine
|
June 7, 2007
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis
Philip D Home, Stuart J Pocock, Henning Beck-Nielsen, et al.
Journal of Cardiac Failure
|
April 21, 2025
NSAIDs Use, Kidney Outcomes and the Effect of Empagliflozin: An Analysis from EMPEROR-Preserved
João Pedro Ferreira, Faiez Zannad, Francisco Vasques-Nóvoa, et al.
Page
of 35